Please ensure Javascript is enabled for purposes of website accessibility

Why Express Scripts Lost Big Today

By Dave Williamson – Feb 21, 2014 at 8:22PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

One loser in the health-care space today: Express Scripts. Here's what happened.

Express Scripts (ESRX) fell 4% today, a big fall for a $60 billion company, after it delivered its fourth-quarter earnings. While the company's revenue and adjusted earnings were just in line with expectations, and guidance landed right around what analysts were estimating, as well, the market clearly reacted today to a few disturbing trends within the company.

Revenue for ESRX has declined both year over year for the last two quarters, as well as sequentially, in three out of the past four. While the company has seen earnings per share increase, this was largely due to share buybacks, which are expected to continue. David notes that organic script growth is in decline in 2014, and in this segment from Friday's Market Checkup, he notes that he'll be digging into comments from the company regarding Obamacare, how that legislation is changing its relationships, and if the company plans to keep growing through acquisitions.

David Williamson owns shares of Express Scripts. The Motley Fool recommends Express Scripts. The Motley Fool owns shares of Express Scripts. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Stocks Mentioned

Express Scripts Holding Company Stock Quote
Express Scripts Holding Company

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.